Review



crispr-cas9 crrna  (Integrated DNA Technologies)


Bioz Verified Symbol Integrated DNA Technologies is a verified supplier
Bioz Manufacturer Symbol Integrated DNA Technologies manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Integrated DNA Technologies crispr-cas9 crrna
    Crispr Cas9 Crrna, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 95/100, based on 724 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crispr-cas9-crrna/CRISPR-Cas9+crRNA/custom%40crispr-cas9-crrna%4042830950
    Average 95 stars, based on 724 article reviews
    crispr-cas9 crrna - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    Membrane:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Incubation:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Transfection:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Oligomer Restriction:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Software:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Ubiquitin Proteomics:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Sequencing:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Amplification:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Activated Clotting Time Assay:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    DNA Sequencing:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Concentration Assay:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Blocking Assay:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Disruption:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Knock-Out:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub

    Gene Knockout:

    Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells
    Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 (IDT), and Alt-R CRISPR-Cas9 crRNA (IDT) as previously described. 26 EnGen Cas9 NLS and S. pyogenes (NEB) proteins were incubated with prepared gRNAs to form ribonucleoprotein complexes, which were sub



    Similar Products

    95
    Integrated DNA Technologies crispr-cas9 crrna
    Crispr Cas9 Crrna, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crispr-cas9-crrna/CRISPR-Cas9+crRNA/custom%40crispr-cas9-crrna%4042830950
    Average 95 stars, based on 1 article reviews
    crispr-cas9 crrna - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results